MIM
NUTX

MetLife Investment Management’s Nutex Health NUTX Stock Holding History

MetLife Investment Management’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$274K Buy
2,884
+755
+35% +$92.6K ﹤0.01% 2058
2025
Q4 		$350K Hold
2,129
– – ﹤0.01% 1964
2025
Q3 		$220K Hold
2,129
– – ﹤0.01% 2266
2025
Q2 		$265K Buy
+2,129
New +$275K ﹤0.01% 2026
2023
Q2 		– Sell
-916
Closed -$139K – 2973
2023
Q1 		$139K Hold
916
– – ﹤0.01% 2415
2022
Q4 		$261K Buy
+916
New +$176K ﹤0.01% 2079

Other funds holding NUTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $605M AUM 26.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WC
Winmill & Co Rochester, New York $347M AUM 37.48% 1-Year Est. Return

MetLife Investment Management's NUTX Position: Q1 2026 in Review

MetLife Investment Management increased its Nutex Health (NUTX) stake by 35% in Q1 2026, buying an estimated $92.6K and bringing the position to 2,884 shares worth $274K. The position accounts for ﹤0.01% of the portfolio, ranked #2058.

MetLife Investment Management first reported a position in NUTX in Q4 2022 and has held it in 6 quarters since. The position peaked at $350K in Q4 2025. 129 funds tracked by Wall St. Rank hold NUTX as of Q1 2026.

  • MetLife Investment Management held 2,884 shares of Nutex Health worth $274K as of Q1 2026.
  • MetLife Investment Management bought 755 Nutex Health shares in Q1 2026, an estimated $92.6K.
  • Nutex Health made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2058 holding.
  • MetLife Investment Management first reported a position in Nutex Health in Q4 2022 and has held it in 6 quarters since.
  • MetLife Investment Management's Nutex Health position peaked at $350K in Q4 2025.
  • 129 funds tracked by Wall St. Rank held Nutex Health as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.